Moberg Pharma Financials
| MOB Stock | SEK 9.53 0.61 6.84% |
Moberg |
Please note, the imprecision that can be found in Moberg Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Moberg Pharma AB. Check Moberg Pharma's Beneish M Score to see the likelihood of Moberg Pharma's management manipulating its earnings.
Moberg Pharma Stock Summary
Moberg Pharma competes with Mendus AB, BioInvent International, Orexo AB, Oncopeptides, and Saniona AB. Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0003613090 |
| Business Address | GustavslundsvAegen 42, Bromma, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.mobergpharma.se |
| Phone | 46 8 52 23 07 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Moberg Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Moberg Stock, because this is throwing your money away. Analyzing the key information contained in Moberg Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Moberg Pharma Key Financial Ratios
Moberg Pharma's financial ratios allow both analysts and investors to convert raw data from Moberg Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Moberg Pharma over time and compare it to other companies across industries.| Return On Equity | -0.0325 | |||
| Return On Asset | -0.0249 | |||
| Target Price | 8.0 | |||
| Beta | 0.8 | |||
| Z Score | 9.6 |
Moberg Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Moberg Pharma's current stock value. Our valuation model uses many indicators to compare Moberg Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Moberg Pharma competition to find correlations between indicators driving Moberg Pharma's intrinsic value. More Info.Moberg Pharma AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Moberg Pharma's earnings, one of the primary drivers of an investment's value.Moberg Pharma AB Systematic Risk
Moberg Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Moberg Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Moberg Pharma AB correlated with the market. If Beta is less than 0 Moberg Pharma generally moves in the opposite direction as compared to the market. If Moberg Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Moberg Pharma AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Moberg Pharma is generally in the same direction as the market. If Beta > 1 Moberg Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Moberg Pharma January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Moberg Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Moberg Pharma AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Moberg Pharma AB based on widely used predictive technical indicators. In general, we focus on analyzing Moberg Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Moberg Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 51.01 | |||
| Value At Risk | (6.52) | |||
| Potential Upside | 9.47 |
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.